https://www.taxtmi.com/news?id=30558 Amrith Noni Artho Plus completed a CTRI registered double blind, randomized, placebo controlled human trial for osteoarthritis, rheumatoid arthritis, and gout, reporting improvements in clinical symptoms, biochemical markers, mineral and bone density measures, and organ function with no reported side effects; the study's registration and randomized methodology are presented as the basis for scientific validation of the product's efficacy. en-us Fri, 17 Jan 2025 14:46:03 +0530 Fri, 17 Jan 2025 14:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=30558 Amrith Noni Artho Plus completed a CTRI registered double blind, randomized, placebo controlled human trial for osteoarthritis, rheumatoid arthritis, and gout, reporting improvements in clinical symptoms, biochemical markers, mineral and bone density measures, and organ function with no reported side effects; the study's registration and randomized methodology are presented as the basis for scientific validation of the product's efficacy. News - Fri, 17 Jan 2025 14:46:03 +0530 https://www.taxtmi.com/news?id=30558